Nobivac for Canine 3-DAPv (25 Doses) - [Vaccine]

Nobivac Canine 3-DAPv is a modified live virus vaccine recommended for the vaccination of healthy dogs to prevent disease caused by canine distemper virus and canine parvovirus, and as an aid in the prevention of disease caused by canine adenovirus types 1 and 2 (infectious canine hepatitis and tracheobronchitis). The vaccine provides up to three years of protection following proper initial and booster vaccinations.

Canine Distemper, Adenovirus Type 2, Parvovirus Vaccine – MODIFIED LIVE VIRUS

This proven 3-year vaccine offers comprehensive and lasting immunity against three of the most common and serious canine viral infections.

Key Benefits of Nobivac Canine 3-DAPv

• Provides broad-spectrum protection against canine distemper virus, adenovirus type 2 (CAV-2), and parvovirus (CPV)
• Challenge studies demonstrated 100% protection for 3 years against distemper, adenovirus type 1, and parvovirus¹
• Formulated with CPV STRAIN 154® to help override maternal antibodies and induce early immunity^1–2
• Serologic testing showed high antibody titers throughout the 3-year post-vaccination period¹
• Utilizes the Manhattan strain of CAV-2 to protect against CAV-1 (hepatitis) while minimizing the risk of adverse reactions
• Effective against circulating field strains of CPV
• Protects against infectious canine hepatitis (CAV-1) and infectious tracheobronchitis (CAV-2)
• Recommended as a core vaccine for comprehensive viral protection in dogs

Indications

• Indicated for the vaccination of healthy dogs to prevent disease caused by canine distemper virus and as an aid in preventing disease caused by canine adenovirus types 1 and 2, and canine parvovirus
• Provides protection for up to 3 years following completion of the initial series and subsequent booster
• Recommended for use in healthy dogs 7 weeks of age or older

Directions for Use

• Administer 1 mL subcutaneously to healthy dogs as early as 7 weeks of age.
• Repeat with 1 mL booster doses every 3 to 4 weeks until the dog reaches 12 weeks of age.
• Dogs over 12 weeks should receive two 1 mL doses, 3–4 weeks apart, for primary immunization.
• Revaccinate every 3 years with a single 1 mL dose.

Safety Information

• Safe for administration to puppies as young as 7 weeks of age.
• High-titer strains of canine parvovirus (CPV) and distemper virus proven safe for dogs as young as 4 weeks of age.
• No vaccine-related adverse reactions or injection site issues were reported in challenge studies.

Precautions

• Store between 2°C–7°C (35°F–45°F).
• Do not freeze.
• Do not mix with other vaccines or veterinary products.
• Use sterile, non-chemically sterilized needles and syringes.
• Burn all unused vaccine and empty containers following use.

Warnings

• Contains gentamicin as a preservative.
• Vaccinate only healthy, parasite-free dogs.
• Do not vaccinate pregnant bitches.
• Biological products may cause anaphylaxis or immune-mediated hypersensitivity reactions.
• Emergency Treatment: Epinephrine, corticosteroids, and antihistamines may be indicated depending on the reaction.
• The timing of active immunity development varies depending on the bitch's antibody levels and the puppy’s absorption of colostral antibodies.